A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers

Published:2022-07 Issue:7 Volume:298 Page:102063
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Liu Zi,Huang Liancheng,Zhou Tianhao,Chang Xing,Yang Yuying,Shi Yani,Hao Mingjing,Li Zengqiang,Wu Yingliang,Guan Qi,Zhang Weige,Zuo Daiying

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. RNA-based therapies: a cog in the wheel of lung cancer defense;Khan;Mol. Cancer,2021

2. Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC);Makhov;Oncogenesis,2021

3. The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review;Liu;Transl. Lung Cancer Res.,2021

4. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis;Li;Trans. Lung Cancer Res.,2021

5. Implementation of CRISPR/Cas9 genome editing to generate murine lung cancer models that depict the mutational landscape of human disease;Hartmann;Front. Cell Dev. Biol.,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma;Journal of Dental Research;2024-08

2. Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer;Cancer Letters;2024-08

3. Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer;2024-05-23

4. Synthesis of Competitive and Noncompetitive Inhibitors of Alpha‐Glucosidase and Anticancer Agents;Chemistry & Biodiversity;2024-03-28

5. The microbiome in the pathogenesis of lung cancer;APMIS;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3